Medical News

RSS

Novel approach to detect flaws in defense against breast cancer earns Era of Hope Scholar Award

A novel approach to detecting and targeting flaws in first line of defense against cancer has earned an Era of Hope Scholar Award from the U.S. Department of Defense for a scientist at The University of Texas M. D. Anderson Cancer Center.

2 Dec 2009

Fruit flies use same molecular mechanisms as humans for maintaining cholestrol

More importantly, according to two new studies led by a University of Utah human geneticist, fruit flies use the same molecular mechanisms as humans to help maintain proper balances of cholesterol and a key form of stored fat that contributes to obesity. The findings mean that as researchers try to learn more about the genetic and biological processes through which people regulate cholesterol and fat metabolism, the humble fruit fly, also called Drosophila, can teach humans much about themselves.

2 Dec 2009

Aspen Brook Consulting announces 2010 Bioprocess Management Summit

Aspen Brook Consulting, Inc., announces the 2010 Bioprocess Management Summit. This event, occurring February 24th-26th, 2010 at The Canyons Hotel and Conference Center in Park City UT, has been designed as a forum where members of the bioprocess community gather annually to share their knowledge and experience in an effort to address challenges facing the biopharmaceutical industry.

2 Dec 2009

Research finds change in the outlook of people with type 2 diabetes and heart disease

The outlook for individuals with type 2 diabetes and coronary artery disease is not as grim as originally believed, according to new Saint Louis University research published in Circulation, the Journal of the American Heart Association.

2 Dec 2009

Champions Biotechnology and Ramot establish licensing agreement

Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.

2 Dec 2009

MIT scientists develop computer models to predict realistic drug delivery patterns from stents

MIT scientists including Elazer R. Edelman, the Thomas D. and Virginia W. Cabot Professor of Health Science and Technology (HST), and HST postdoctoral associate Vijaya B. Kolachalama, developed computer models to predict physiologically realistic drug delivery patterns from stents in branched arterial vessels.

2 Dec 2009

Researchers discover ability of stem cells in brain cancer glioma to resist radiation therapy

Duke University Medical Center researchers have figured out how stem cells in the malignant brain cancer glioma may be better able to resist radiation therapy. And using a drug to block a particular signaling pathway in these cancer stem cells, they were able to kill many more glioma cells with radiation in a laboratory experiment.

2 Dec 2009

Clinical groups discuss the usage of EAS in adults and children

Electric acoustic stimulation (EAS) combines electric stimulation in the mid- to high-frequency regions with acoustic stimulation in the low-frequency range with the aim to preserve residual low-frequency hearing after cochlear implantation, which together particularly improves speech understanding, pitch discrimination and music appreciation.

2 Dec 2009

Adult stem cells may help repair heart tissue, reveals new study

Adult stem cells may help repair heart tissue damaged by heart attack according to the findings of a new study to be published in the December 8 issue of the Journal of the American College of Cardiology. Results from the Phase I study show stem cells from donor bone marrow appear to help heart attack patients recover better by growing new blood vessels to bring more oxygen to the heart.

2 Dec 2009

MSC's Quality Initiative Programs to be highlighted at the 2009 IHI National Forum

Medical Simulation Corporation (MSC) will highlight its full menu of Quality Initiative Programs at the 2009 IHI National Forum, December 7-9, 2009, in Orlando, Florida. MSC is the first simulation company to introduce simulation-based education programs that help healthcare providers bridge the gap between measurement and achievement of publicly reported patient safety and quality initiatives.

2 Dec 2009

New CareTracker Clinical Intelligence technology to be introduced in 187 health centers

Resource Systems, developer of long-term care electronic documentation system CareTracker, and Extendicare Health Services, Inc., a leading provider of senior care with over 260 health centers across U.S. and Canada, announce Extendicare's commitment to introduce the new CareTracker Clinical Intelligence technology to 187 health centers. The Clinical Intelligence tool assists health centers in predicting and notifying caregivers of potential resident care issues before they become a problem.

2 Dec 2009

Study on the genetics of osteoarthritis

Interleukin Genetics, Inc. and NYU Langone Medical Center announced findings from a study performed in collaboration with Duke University on the genetics of osteoarthritis have been published this week in the "Online First" version of the Annals of Rheumatic Diseases and is available at http://ard.bmj.com/cgi/rapidpdf/ard.2009.113043v1.pdf.

2 Dec 2009

Javelin Pharmaceuticals submits an NDA for Dyloject Injection

Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.

2 Dec 2009

Vitro Diagnostics files a patent application for its technology related to generation of iPS cells

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the filing of a new United States patent application entitled “POU5-F1 Expression in Human Mesenchymal Stem Cells” and the development of new technology related to generation of human induced pluripotent stem cells (iPS).

2 Dec 2009

University of Pittsburgh's McGowan Institute for Regenerative Medicine awarded IBM SUR grant

The University of Pittsburgh's McGowan Institute for Regenerative Medicine, which connects scientists who work on tissue engineering, cell therapies, artificial organs and biodevices, has been awarded a Shared University Research (SUR) Award from IBM ( IBM). The IBM SUR Award will provide IBM computer hardware, software and services to Pitt for its cutting-edge "in silico" biological research, which uses computer simulations to explore biological pathways and test therapeutic interventions.

2 Dec 2009

Women at high risk of developing breast cancer reluctant to take tamoxifen for prevention

Even when women at high-risk of breast cancer are well-informed about the risks and benefits of using the drug tamoxifen for prevention, only 6 percent said they were likely to take it.

2 Dec 2009

Senators consider women's insurance amendment, Medicare funding issues, with votes likely today

The New York Times: "In a day of desultory debate on sweeping health care legislation, senators appealed to two potent political constituencies ... with Democrats seeking additional medical benefits for women and Republicans vowing to preserve and protect Medicare for older Americans. The Democrats' first amendment, offered by Senator Barbara A. Mikulski of Maryland, would require insurers to cover more screenings and preventive care for women, with no co-payments."

2 Dec 2009

Patient enrollment complete in Peregrine Pharmaceuticals' Cotara trial

Peregrine Pharmaceuticals, Inc. today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with relapsed glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara is a targeted monoclonal antibody linked to a radioisotope being developed as a potential new treatment for GBM.

2 Dec 2009

Partisan sniping dominates Senate health debate

The Christian Science Monitor: In the coming days, "senators will have to grind through lots of [amendments], as members of both parties line up to try and shape the final product. ... Senate debate on Tuesday began at around 2:15 pm, and quickly formed along expected lines. Sen. Charles Grassley (R) of Iowa, ranking minority member on the Finance Committee, led off by complaining about the size and possible expense of the effort, layered on top of federal bailouts of banks and auto firms.

2 Dec 2009

Phosphagenics commences Phase 1B clinical trial of its oxycodone/TPM transdermal patch systems

Phosphagenics Limited today announced the initiation of a Phase 1B clinical trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.

2 Dec 2009

Medical News

Novel approach to detect flaws in defense against breast cancer earns Era of Hope Scholar Award

Fruit flies use same molecular mechanisms as humans for maintaining cholestrol

Aspen Brook Consulting announces 2010 Bioprocess Management Summit

Research finds change in the outlook of people with type 2 diabetes and heart disease

Champions Biotechnology and Ramot establish licensing agreement

MIT scientists develop computer models to predict realistic drug delivery patterns from stents

Researchers discover ability of stem cells in brain cancer glioma to resist radiation therapy

Clinical groups discuss the usage of EAS in adults and children

Adult stem cells may help repair heart tissue, reveals new study

MSC's Quality Initiative Programs to be highlighted at the 2009 IHI National Forum

New CareTracker Clinical Intelligence technology to be introduced in 187 health centers

Study on the genetics of osteoarthritis

Javelin Pharmaceuticals submits an NDA for Dyloject Injection

Vitro Diagnostics files a patent application for its technology related to generation of iPS cells

University of Pittsburgh's McGowan Institute for Regenerative Medicine awarded IBM SUR grant

Women at high risk of developing breast cancer reluctant to take tamoxifen for prevention

Senators consider women's insurance amendment, Medicare funding issues, with votes likely today

Patient enrollment complete in Peregrine Pharmaceuticals' Cotara trial

Partisan sniping dominates Senate health debate

Phosphagenics commences Phase 1B clinical trial of its oxycodone/TPM transdermal patch systems

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News